Skip to content
Back to PALI

Palisade Bio, Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
14
Purchases
10
Sales
4
Purchase value
$296.74K
Sale value
$420.18K

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Donald Allen WilliamsDirector
4
Filed Oct 5, 2026Period of report Oct 1, 20260001493152-26-045772
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseOct 2, 2026
Common Stock10,000$1.46$14.60K1,590,294Direct
PurchaseOct 1, 2026
Common Stock10,000$1.42$14.20K1,580,294Direct
Open on SEC EDGAR
Robert Baltera Jr.Director
4
Filed Jul 10, 2026Period of report Jul 8, 20260001493152-26-032884
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseJul 9, 2026
Common StockF225,000$1.956$48.90K461,904Direct
PurchaseJul 8, 2026
Common StockF120,000$1.9899$39.80K436,904Direct
Filing footnotes · 2
  1. F1The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.98 to $2.00. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  2. F2The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.9298 to $1.98. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Open on SEC EDGAR
Robert Baltera Jr.Director
4
Filed Jul 8, 2026Period of report Jul 6, 20260001493152-26-032563
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseJul 7, 2026
Common StockF230,000$2.0348$61.04K416,904Direct
PurchaseJul 6, 2026
Common StockF120,000$2.052$41.04K386,904Direct
Filing footnotes · 2
  1. F1The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.04 to $2.068. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  2. F2The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.00 to $2.07. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Open on SEC EDGAR
Mitchell Lawrence JonesChief Medical Officer
4
Filed Jul 8, 2026Period of report Jul 6, 20260001493152-26-032561
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 7, 2026
Common StockF3F451,880$2.0535$106.54K94,009Direct
Filing footnotes · 6
  1. F1The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs") granted on February 9, 2026.
  2. F2Includes 1,459 shares acquired under the Issuer's Employee Stock Purchase Plan on May 20, 2026.
  3. F3The sale reported in this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs.
  4. F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.045 to $2.06, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
  5. F5Each RSU represents a contingent right to receive one share of the Issuer's common stock.
  6. F6The RSUs shall vest with respect to 1/6th of the shares on July 6, 2026 and quarterly thereafter over the following 10 quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.
Open on SEC EDGAR
John David FinleyDirector · CEO, CFO
4
Filed Jul 8, 2026Period of report Jul 6, 20260001493152-26-032559
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 7, 2026
Common StockF3F4146,798$2.0664$303.34K217,555Direct
Filing footnotes · 10
  1. F1The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs") granted on February 9, 2026.
  2. F10Represents Series 2 Common Stock Purchase Warrants received as part of the Units purchased by Reporting Person. The Series 2 Warrants became exercisable upon receipt of stockholder approval per Nasdaq rules, which was obtained on October 6, 2022.
  3. F2Includes 1,899 shares acquired under the Issuer's Employee Stock Purchase Plan on May 20, 2026. In addition, the amount of securities beneficially owned was reduced by 66 shares due to an administrative error in the total reported in the Form 4 filed February 13, 2026.
  4. F3The sale reported in this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs.
  5. F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.045 to $2.09, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
  6. F5The Reporting Person is the managing member of FCW Investments, LLC and has the sole investment and voting power over the securities held by this entity.
  7. F6Each RSU represents a contingent right to receive one share of the Issuer's common stock.
  8. F7The RSUs shall vest with respect to 1/6th of the shares on July 6, 2026 and quarterly thereafter over the following 10 quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.
  9. F8As adjusted in accordance with the terms of the Series 2 Common Stock Purchase Warrants following the public offering that closed on October 2, 2025.
  10. F9Reflects adjustments pursuant to the Issuer's 1-for-50 reverse stock split effective November 15, 2022, and the Issuer's 1-for-15 reverse stock split effective April 5, 2024.
Open on SEC EDGAR
Robert Baltera Jr.Director
4
Filed Jul 6, 2026Period of report Jul 1, 20260001493152-26-032229
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseJul 2, 2026
Common StockF110,000$1.98$19.80K366,904Direct
PurchaseJul 1, 2026
Common StockF120,000$1.98$39.60K356,904Direct
Filing footnotes · 1
  1. F1The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.97 to $1.99. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Open on SEC EDGAR
Mitchell Lawrence JonesChief Medical Officer
4
Filed Feb 13, 2026Period of report Feb 11, 20260001493152-26-006833
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 12, 2026
Common StockF31,989$1.75$3.48K13,263Direct
Filing footnotes · 5
  1. F1The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs") granted on February 11, 2025.
  2. F2Includes 3,400 shares acquired under the Issuer's Employee Stock Purchase Plan on November 20, 2025.
  3. F3The sale reported in this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs.
  4. F4Each RSU represents a contingent right to receive one share of the Issuer's common stock.
  5. F5The RSUs shall vest in three equal annual installments beginning on February 11, 2026, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.
Open on SEC EDGAR
John David FinleyDirector · CEO, CFO
4
Filed Feb 13, 2026Period of report Feb 11, 20260001493152-26-006831
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 12, 2026
Common StockF33,896$1.75$6.82K27,353Direct
Filing footnotes · 6
  1. F1The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs") granted on February 11, 2025.
  2. F2Includes 4,444 shares acquired under the Issuer's Employee Stock Purchase Plan on November 20, 2025.
  3. F3The sale reported in this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs.
  4. F4Reporting Person is the managing member of FCW Investments, LLC and has the sole investment and voting power over the securities held by this entity.
  5. F5Each RSU represents a contingent right to receive one share of the Issuer's common stock.
  6. F6The RSUs shall vest in three equal annual installments beginning on February 11, 2026, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.
Open on SEC EDGAR
Donald Allen WilliamsDirector
4
Filed Jan 21, 2026Period of report Jan 16, 20260001493152-26-003078
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseJan 16, 2026
Common Stock5,000$1.6712$8.36K10,728Direct
Open on SEC EDGAR
Donald Allen WilliamsDirector
4
Filed Jan 13, 2026Period of report Jan 9, 20260001493152-26-002107
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseJan 9, 2026
Common Stock5,000$1.88$9.40K5,728Direct
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.